SCHEMBL8354825

SCHEMBL8354825

COc1ccc(C(=O)n2c(C)[c]c3cc(OC)ccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 7/20 0.51
▸ AKR1C2 P52895 6/20 0.51
▸ CNR2 P34972 1/20 0.45
▸ PTGS2 P35354 4/20 0.45
▸ NPSR1 Q6W5P4 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ PTGS1 P23219 3/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ LMNA P02545 2/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ CYP2D6 P10635 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ HIF1A Q16665 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ PTGES O14684 1/20 0.45
▸ ABCC3 O15438 1/20 0.45
▸ ABCC4 O15439 1/20 0.45
▸ ABCB11 O95342 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4663300 0.92 AKR1C3 (0.62) AKR1C3AKR1C2CNR2PTGS2NPSR1
SCHEMBL8354130 0.92 LMNA (0.54) AKR1C3AKR1C2CNR2PTGS2NPSR1
SCHEMBL5554558 0.89 AKR1C3 (0.47) AKR1C3AKR1C2PTGS2PTGS1PPARG
SCHEMBL4377895 0.89 AKR1C3 (0.57) AKR1C3AKR1C2PTGS2
SCHEMBL8360216 0.86 CNR2 (0.46) AKR1C3AKR1C2CNR2PTGS2AKR1C4
SCHEMBL5797505 0.76 TRPV1 (0.40) AKR1C3AKR1C2ALOX5PPARG
SCHEMBL8358773 0.74 CNR2 (0.44) AKR1C3AKR1C2CNR2PTGS2NPSR1
SCHEMBL8354821 0.74 RAB9A (0.47) KMT2AALDH1A1MEN1ALOX5RAB9A
SCHEMBL2075064 0.72 ALDH1A1 (0.45) NPSR1MAPTKMT2AALDH1A1KDM4E
SCHEMBL2073237 0.72 AKR1B1 (0.46) KDM4EAKR1B1PTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 — — US disclosed
Send feedback